An In Vitro and In Vivo Analysis of the Correlation between Susceptibility-Weighted Imaging Phase Values and R2* in Cirrhotic Livers

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Tao, Ran ^a,c   Zhang, Jiuquan ^a   Dai, Yongming ^b   You, Zhonglan ^a   Fan, Yi ^a   Cui, Jinguo ^c   Wang, Jian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Siemens Healthcare ^*  (China)

^c BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; IRON; MANGANESE CHLORIDE;

ADULT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS B; HUMAN; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; IRON METABOLISM DISORDER; IRON STORAGE; LIVER CIRRHOSIS; LIVER LEVEL; MAJOR CLINICAL STUDY; MALE; MULTI ECHO T2 WEIGHTED IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHANTOM; SIGNAL PROCESSING; SUSCEPTIBILITY WEIGHTED IMAGING;

ADULT; CASE-CONTROL STUDIES; FEMALE; FERRITINS; HUMANS; IRON; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHANTOMS, IMAGING; YOUNG ADULT;

EID: 84866481235     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045477     Document Type: Article

References (35)

1. Beinker NK, Voigt MD, Arendse M, Smit J, Stander IA, et al. (1996) Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol. 25: 633-638.
2. Metwally MA, Zein CO, Zein NN, (2004) Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 99: 286-291.
3. Olthof AW, Sijens PE, Kreeftenberg HG, Kappert P, Irwan R, et al. (2007) Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation. Magn Reson Imaging 25: 228-231.
4. Kim MJ, Mitchell DG, Ito K, Hann HW, Park YN, et al. (2001) Hepatic iron deposition on MR imaging in patients with chronic liver disease: correlation with serial serum ferritin concentration. Abdom Imaging 26: 149-156.
5. Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M, (1996) Variability in hepatic iron concentration measurement from needle-biopsy specimens. J Hepatol 25: 172-177.
6. Szurowska E, Sikorska K, Izycka-Swieszewska E, Nowicki T, Romanowski T, et al. (2010) The role of MR imaging in detection of hepatic iron overload in patients with cirrhosis of different origins. BMC Gastroenterol 10: 13.
7. Gandon Y, Olivie D, Guyader D, Aube C, Oberti F, et al. (2004) Non-invasive assessment of hepatic iron stores by MRI. Lancet 363: 357-362.
8. Alustiza JM, Artetxe J, Castiella A, Agirre C, Emparanza JI, et al. (2004) MR quantification of hepatic iron concentration. Radiology 230: 479-484.
9. Fenzi A, Bortolazzi M, Marzola P, Colombari R, (2001) In vivo investigation of hepatic iron overload in rats using T2 maps: quantification at high intensity field (4.7-T). J Magn Reson Imaging 13: 392-396.
10. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, et al. (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106: 1460-1465.
11. Chandarana H, Lim RP, Jensen JH, Hajdu CH, Losada M, et al. (2009) Hepatic iron deposition in patients with liver disease: preliminary experience with breath-hold multiecho T2*-weighted sequence. AJR Am J Roentgenol 193: 1261-1267.
12. Virtanen JM, Komu ME, Parkkola RK, (2008) Quantitative liver iron measurement by magnetic resonance imaging: in vitro and in vivo assessment of the liver to muscle signal intensity and the R2* methods. Magn Reson Imaging 26: 1175-1182.
13. Haacke EM, Xu Y, Cheng YC, Reichenbach JR, (2004) Susceptibility weighted imaging (SWI). Magn Reson Med 52: 612-618.
14. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, et al. (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 23: 1-25.
15. McCrea RP, Harder SL, Martin M, Buist R, Nichol H, (2008) A comparison of rapid-scanning X-ray fluorescence mapping and magnetic resonance imaging to localize brain iron distribution. Eur J Radiol 68: S109-113.
16. Haacke EM, Ayaz M, Khan A, Manova ES, Krishnamurthy B, et al. (2007) Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 26: 256-264.
17. Dai Y, Zeng M, Li R, Rao S, Chen C, et al. (2011) Improving detection of siderotic nodules in cirrhotic liver with a multi-breath-hold susceptibility-weighted imaging technique. J Magn Reson Imaging 34: 318-325.
18. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, et al. (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105: 855-861.
19. Ulmer JL, Mathews VP, Hamilton CA, Elster AD, Moran PR, (1996) Magnetization transfer or spin-lock? An investigation of off-resonance saturation pulse imaging with varying frequency offsets. AJNR Am J Neuroradiol 17: 805-819.
20. Vymazal J, Zak O, Bulte JW, Aisen P, Brooks RA, (1996) T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 36: 61-65.
21. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, et al. (1997) Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 113: 1609-1616.
22. Harbin WP, Robert NJ, Ferrucci JT Jr, (1980) Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 135: 273-283.
23. Ito K, Mitchell DG, Siegelman ES (2002) Cirrhosis: MR imaging features. Magn Reson Imaging Clin N Am 10: 75-92, vi.
24. Wang Y, Yu Y, Li D, Bae KT, Brown JJ, et al. (2000) Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging 12: 661-670.
25. McCarville MB, Hillenbrand CM, Loeffler RB, Smeltzer MP, Song R, et al. (2010) Comparison of whole liver and small region-of-interest measurements of MRI liver R2* in children with iron overload. Pediatr Radiol 40: 1360-1367.
26. Haacke EM, Miao Y, Liu M, Habib CA, Katkuri Y, et al. (2010) Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J Magn Reson Imaging 32: 561-576.
27. Ito K, Mitchell DG, (2004) Imaging diagnosis of cirrhosis and chronic hepatitis. Intervirology 47: 134-143.
28. Emond MJ, Bronner MP, Carlson TH, Lin M, Labbe RF, et al. (1999) Quantitative study of the variability of hepatic iron concentrations. Clin Chem 45: 340-346.
29. Mugler JP III (2006) Basic principles. In: Edelman RR, Hesselink JR ZM, Crues JV, eds. Clinical magnetic resonance imaging. 3rd ed. Philadelphia, Pa: Saunders Elsevier, 23-57.
30. Haacke EM, Reichenbach JR (2011) Susceptibility Weighted Imaging in MRI: Basic Concepts and Clinical Applications. Hoboken, New Jersey, John Wiley&Sons, p.10.
31. Shmueli K, de Zwart JA, van Gelderen P, Li TQ, Dodd SJ, et al. (2009) Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med 62: 1510-1522.
32. Rauscher A, Barth M, Reichenbach JR, Stollberger R, Moser E, (2003) Automated unwrapping of MR phase images applied to BOLD MR-venography at 3 Tesla. J Magn Reson Imaging 18: 175-180.
33. Deistung A, Dittrich E, Sedlacik J, Rauscher A, Reichenbach JR, (2009) ToF-SWI: simultaneous time of flight and fully flow compensated susceptibility weighted imaging. J Magn Reson Imaging 29: 1478-1484.
34. Du YP, Jin Z, Hu Y, Tanabe J, (2009) Multi-echo acquisition of MR angiography and venography of the brain at 3 Tesla. J Magn Reson Imaging 30: 449-454.
35. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC, (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 30: 19-30.